Sign Up to like & get
recommendations!
1
Published in 2019 at "Neurobiology of Disease"
DOI: 10.1016/j.nbd.2019.104495
Abstract: CuATSM is a PET-imaging agent that has recently received attention for its success in extending the lifespan in animals in several neurodegenerative disease models. In the SOD1G93A model of ALS, CuATSM prolonged mouse longevity far…
read more here.
Keywords:
model;
mouse model;
motor neuron;
cuatsm ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "ACS chemical neuroscience"
DOI: 10.1021/acschemneuro.2c00253
Abstract: CuATSM has repeatedly demonstrated to be therapeutically effective in SOD1 mouse models of amyotrophic lateral sclerosis (ALS), leading to current clinical trials. CuATSM acts to stabilize ALS-associated mutant SOD1 protein by supplying copper. However, in…
read more here.
Keywords:
copper;
cuatsm associated;
als associated;
sod1 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "ACS chemical neuroscience"
DOI: 10.1021/acschemneuro.8b00527
Abstract: Mutations in the SOD1 gene are associated with some forms of familial amyotrophic lateral sclerosis (fALS). There are more than 150 different mutations in the SOD1 gene that have various effects on the copper-zinc superoxide…
read more here.
Keywords:
copper zinc;
sod1;
copper;
metal binding ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "International Journal of Nanomedicine"
DOI: 10.2147/ijn.s241756
Abstract: Purpose Most solid tumors contain areas of chronic hypoxia. Gold nanoparticles (GNP) have been extensively explored as enhancers of external beam radiation; however, GNP have lower cellular uptake in hypoxic conditions than under normoxic conditions.…
read more here.
Keywords:
hypoxic;
cuatsm;
external beam;
dose enhancement ... See more keywords